IA4Clinical Trials Symposium
- il y a 4 heures
- 1 min de lecture
Yesterday, more than 120 participants gathered at The Hive for the AI 4 Clinical Trials Symposium, co-organised by Future4Care and PSCC Connect.
The day opened with an inspiring keynote by Stéphanie Allassonnière (Université Paris Cité), "Smarter Trials, Faster Cures: The AI Revolution in Clinical Research." Her presentation highlighted a clear message: AI is no longer a promise—it is already transforming every stage of clinical research.
Throughout the morning, three expert panels explored some of the most pressing challenges and opportunities for AI in clinical trials:
🔹 Trial Design & Patient Stratification — featuring IQVIA, Orakl, Deeplife and Zebramed, moderated by Servier.
🔹 Patient Recruitment — with Klineo, Qairnel and Biokortex, moderated by Sanofi.
🔹 Clinical Trial Conduct & Data Analysis — with Ariana Pharma, Arcascience, Nova in Silico and Enovacom, moderated by Unicancer.
📣 We also welcomed Laetitia Gambotti (AIS), who presented the France 2030 Call for Expressions of Interest: "New Methodologies for Clinical Research." The programme has already supported 16 projects, helping to bridge the gap between regulatory acceptance and industry investment in innovative AI-driven methodologies.
The symposium concluded with two inspiring patient-centred sessions:
Claire Jouffroy-Zeller (Unicancer) brilliantly synthesised the morning discussions, while Inès Vaz-Luis (Gustave Roussy) highlighted the fact that quality of life is still too rarely considered a primary endpoint in clinical research, and why digital tools have a major role to play in changing this.
A huge thank you to our partner Future4Care, to all our speakers for sharing their expertise, and to everyone who joined us and contributed to such insightful discussions.
See the full report and replay here:
